These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High cost, low volume care: the case of haemophilia. Lee C; Sabin C; Miners A BMJ; 1997 Oct; 315(7114):962-3. PubMed ID: 9365285 [No Abstract] [Full Text] [Related]
5. AIDS grants awarded. Borfitz D Home Health J; 1986 Dec; 7(12):1, 8. PubMed ID: 10279685 [No Abstract] [Full Text] [Related]
6. The natural evolution of haemophilia care: developing and sustaining comprehensive care globally. Evatt BL Haemophilia; 2006 Jul; 12 Suppl 3():13-21. PubMed ID: 16683992 [TBL] [Abstract][Full Text] [Related]
7. Community care networks: cornerstone of health care reform. Davidson RJ J Am Health Policy; 1992; 2(3):12-5. PubMed ID: 10118220 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive care for hemophilia patients in south and west Texas. Zeltzer PM; LeBaron S; Zeltzer L; Yoken C Tex Med; 1988 May; 84(5):45-50. PubMed ID: 3261458 [No Abstract] [Full Text] [Related]
9. Defined contribution plans. Keller M Top Health Care Financ; 1986; 12(4):20-6. PubMed ID: 3726864 [No Abstract] [Full Text] [Related]
10. Optimal haemophilia care versus the reality. Bolton-Maggs PH Br J Haematol; 2006 Mar; 132(6):671-82. PubMed ID: 16487168 [TBL] [Abstract][Full Text] [Related]
11. Impact of strategic financial planning in the health care industry. Anderson D Top Health Care Financ; 1985; 11(4):1-6. PubMed ID: 4012787 [No Abstract] [Full Text] [Related]
12. [The financing characteristics of psychiatric hospitals based on the principle of diagnosis-related (clinico-statistical) groups (a review)]. Rytik EG; Shevchenko LS; Solokhina TA; Seĭku IuV Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(11):107-11. PubMed ID: 1666207 [No Abstract] [Full Text] [Related]
13. Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States. Malouin RA; Mckernan L; Forsberg A; Cheng D; Drake J; McLaughlin K; Trujillo M Matern Child Health J; 2018 Sep; 22(9):1240-1246. PubMed ID: 29948762 [TBL] [Abstract][Full Text] [Related]
14. Cost trends in the treatment for hemophilia: another view. Kletter SD; Rankin PJ Thromb Haemost; 2002 Oct; 88(4):542-4. PubMed ID: 12362222 [No Abstract] [Full Text] [Related]
15. Uncertain times for research on hemophilia and allied disorders. Srivastava A J Thromb Haemost; 2006 Mar; 4(3):680; discussion 681-3. PubMed ID: 16460452 [No Abstract] [Full Text] [Related]
16. The benefits of comprehensive care of hemophilia: a five-year study of outcomes. Smith PS; Levine PH Am J Public Health; 1984 Jun; 74(6):616-7. PubMed ID: 6721023 [TBL] [Abstract][Full Text] [Related]
17. Can costs of hemophilia products be curtailed? Not as we do business today! Aledort LM Thromb Haemost; 2002 Oct; 88(4):541. PubMed ID: 12362221 [No Abstract] [Full Text] [Related]
18. The cost of fragmented mental health financing: is it worth it? Cutler DL; Bigelow D; McFarland B Community Ment Health J; 1992 Apr; 28(2):121-33. PubMed ID: 1611857 [TBL] [Abstract][Full Text] [Related]
19. Strategies for financing home healthcare. Strandell C Home Healthc Nurse; 1991; 9(1):4-8. PubMed ID: 1993617 [TBL] [Abstract][Full Text] [Related]